Loading...
XNAS
NUTX
Market cap1.09bUSD
Jul 09, Last price  
183.36USD
1D
2.12%
1Q
81.45%
Jan 2017
-96.51%
IPO
144.48%
Name

Nutex Health Inc

Chart & Performance

D1W1MN
XNAS:NUTX chart
P/E
15.42
P/S
1.25
EPS
11.89
Div Yield, %
Shrs. gr., 5y
9.50%
Rev. gr., 5y
26.14%
Revenues
875m
+82.36%
220,4691,266,3602,548,6530053,64791,37397,057,120274,029,061331,531,311219,294,306247,646,316479,948,633875,257,000
Net income
71m
+35.67%
605,288158,137-383,39383,809-7,432,241582,062-2,814,24520,923,151105,969,885132,593,328-424,780,446-45,786,61452,179,16870,789,000
CFO
248m
+971.64%
0-889,104-664,57444,907-274,223-714,623-480,04912,124,66486,671,757173,432,48650,607,1081,256,45223,153,807248,125,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
IPO date
Mar 18, 2011
Employees
800
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT